- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/48 - Sulfur atoms
Patent holdings for IPC class C07D 207/48
Total number of patents in this class: 272
10-year publication summary
|
17
|
14
|
26
|
28
|
24
|
19
|
18
|
19
|
15
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daewoong Pharmaceutical Co., Ltd. | 325 |
18 |
| The Regents of the University of California | 19943 |
11 |
| Takeda Pharmaceutical Company Limited | 2696 |
11 |
| Infex Therapeutics Limited | 17 |
9 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 287 |
8 |
| 4SC AG | 77 |
6 |
| Global Blood Therapeutics, Inc. | 183 |
5 |
| HitGen LTD. | 19 |
4 |
| The University of Melbourne | 536 |
4 |
| Hinye Pharmaceutical Co.,Ltd. | 19 |
4 |
| Novartis AG | 10829 |
3 |
| President and Fellows of Harvard College | 5973 |
3 |
| The Trustees of the University of Pennsylvania | 4329 |
3 |
| Abbvie Inc. | 1800 |
3 |
| AbbVie Deutschland GmbH & Co. KG | 261 |
3 |
| The Scripps Research Institute | 1350 |
3 |
| Idorsia Pharmaceuticals Ltd. | 352 |
3 |
| Jiangsu Carephar Pharmaceutical Co., Ltd. | 13 |
3 |
| Zydus Lifesciences Limited | 114 |
3 |
| Orsobio, Inc. | 13 |
3 |
| Other owners | 162 |